Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,339 | -18,744 | -15,981 | -17,509 | -21,958 |
| Depreciation Amortization | 523 | 2,072 | 1,475 | 1,010 | 470 |
| Accounts receivable | 155 | 328 | 131 | 544 | 546 |
| Other Working Capital | -578 | 1,303 | 1,326 | 2,676 | 352 |
| Other Operating Activity | 181 | -5,427 | -2,897 | 3,491 | 15,560 |
| Operating Cash Flow | $-5,058 | $-20,468 | $-15,946 | $-9,788 | $-5,030 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -69 | -600 | -544 | -497 | -187 |
| Purchase Sale Intangibles | N/A | -13 | -13 | -13 | N/A |
| Other Investing Activity | 0 | -13 | -13 | -13 | 0 |
| Investing Cash Flow | $-69 | $-613 | $-557 | $-510 | $-187 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 17,700 | 17,700 | 17,700 | N/A |
| Debt Repayment | N/A | -25,032 | -25,032 | -25,032 | N/A |
| Common Stock Issued | 562 | 34,051 | 31,735 | 29,916 | 3,974 |
| Dividend Paid | N/A | -75 | -75 | -75 | -72 |
| Other Financing Activity | -500 | -5,847 | -3,477 | -2,977 | -123 |
| Financing Cash Flow | $62 | $20,797 | $20,851 | $19,532 | $3,779 |
| Exchange Rate Effect | 85 | N/A | 0 | -14 | 15 |
| Beginning Cash Position | 14,338 | 14,622 | 14,622 | 14,622 | 14,622 |
| End Cash Position | 9,358 | 14,338 | 18,970 | 23,842 | 13,199 |
| Net Cash Flow | $-4,980 | $-284 | $4,348 | $9,220 | $-1,423 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,058 | -20,468 | -15,946 | -9,788 | -5,030 |
| Capital Expenditure | -69 | -611 | -544 | -497 | -187 |
| Free Cash Flow | -5,127 | -21,079 | -16,490 | -10,285 | -5,217 |